GSK to sell remaining 4.2% stake in Haleon
![Haleon | Sharecast graphic / Josh White dl haleon consumer goods products personal care gsk ftse 100 logo](https://img.s3wfg.com/web/img/images_uploaded/9/3/dl-haleon-consumer-goods-products-personal-care-gsk-ftse-100-logo_620x350.jpg)
GSK said on Thursday that it plans to sell its entire remaining 4.2% stake in Haleon.
FTSE 100
8,247.79
16:49 25/06/24
n/a
n/a
FTSE 350
4,537.93
17:15 25/06/24
n/a
n/a
FTSE All-Share
4,493.07
16:54 25/06/24
n/a
n/a
GSK
1,595.00p
16:39 25/06/24
-0.84%
-13.50p
Haleon
332.50p
17:15 25/06/24
-0.54%
-1.80p
Pharmaceuticals & Biotechnology
23,251.07
16:35 25/06/24
0.11%
25.10
The pharmaceutical company will sell about 385m ordinary shares in consumer health business Haleon, which it spun off in July 2022.
GSK initially retained a 12.9% stake in Haleon, but has since sold stakes in May 2023, October 2023 and January 2024.
The final disposal will be conducted through a placing of ordinary shares to institutional investors. GSK said the offer price will be determined by means of an accelerated bookbuild offering process which will start immediately.